CSL vaccine plant cited in FDA letter

July 1, 2010
Manufacturing and Production CSL, GMP, P&G, manufacturing compliance

CSL Biotherapies has been sent a letter by the US Food and Drug Administration which indicates that vials of seasonal …

The magnificant seven: digital strategy quiz

July 1, 2010
Medical Communications, Sales and Marketing Creation Interactive, digital pharma

How healthy is your digital engagement strategy? World-class ‘Olympian’, or ‘gasping for breath’? We’ve put together a quick quiz for …

GSK tipped to lead kidney cancer market

July 1, 2010
Sales and Marketing Kidney cancer, Patorma, Votrient, rcc

GlaxoSmithKline’s kidney cancer drug Votrient has been forecast as a future leader in a marketplace currently dominated by Pfizer. Analysts …

Blog footer

Digital Pharma: First app for psoriasis launched

June 30, 2010
Medical Communications, Sales and Marketing Janssen, app, iphone, psoriasis

Janssen-Cilag UK has unveiled the first psoriasis iPhone app – a disease calculator for healthcare professionals treating the chronic skin condition. It …

No sign of revival in R&D productivity

June 30, 2010
Research and Development drug development, industry, research

New data on the performance of the pharmaceutical industry shows efforts to raise productivity have not yet made an impact. …

Indian flag

US and India advance healthcare co-operation

June 30, 2010
Research and Development, Sales and Marketing India, h1n1, medical schools

The US and India are looking to establish closer ties between their top medical schools. The initiative was one of …

Sanofi acquires US biotech TargeGen

June 30, 2010
Research and Development Sanofi, TargeGen, haematology

Sanofi-Aventis is to buy TargeGen, a US biopharmaceutical company which develops small molecule kinase inhibitors. The drugs are used to …

FDA draft CMC guidance could cut down on red tape

June 30, 2010
Manufacturing and Production FDA, GMP, manufacturing

The FDA has published draft guidance aimed at alleviating the burden on pharmaceutical companies of notifying the agency of minor …

Frank Morich and Haruhiko Hirate join Takeda

June 30, 2010
Sales and Marketing Takeda, appointment, sales and marketing

Takeda has made new two appointments, looking outside the company to fill a brace of executive-level positions. Dr Frank Morich …

Real World Development: Increasing value for patients

June 30, 2010
Research and Development Kinapse, drug development

The traditional drug development paradigm is protracted and costly, with many products failing to deliver commercial or clinical success.We propose …

Contract research news in brief

June 30, 2010
Research and Development CRO

Yet more geographic expansion from leading CROs, with Kendle opening an office in India and PRA International announcing a Hungarian …

Avandia

Avandia probe deepens

June 29, 2010
Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline has come under further scrutiny from the FDA after two new studies showed patients taking its troubled diabetes medication …

NHS trials patient payments

June 29, 2010
NHS, PCT, patient

For the first time patients are to be paid directly by the NHS to allow them to choose how their …

J&J recall plant will be closed all year

June 29, 2010
Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance

The manufacturing facility at the centre of Johnson & Johnson’s product recall woes is likely to stay closed until at …

DPT promotes JJ Feik

June 29, 2010
Manufacturing and Production DPT Laboratories, appointment, manufacturing and production

Contract development and manufacturing company DPT Laboratories has promoted JJ Feik to senior director of business development. He was previously …

Chemists find easier method for drug synthesis

June 29, 2010
Manufacturing and Production manufacturing

Researchers in the US have developed a new synthetic pathway that could make the development of new pharmaceuticals quicker, cleaner …

Boehringer cheered by diabetes data

June 28, 2010
Research and Development Boehringer, DPP-4, diabetes, linagliptin

Boehringer Ingelheim has been cheered by phase III data showing its new oral once-daily type II diabetes tablet linagliptin significantly …

Digital Pharma: The smokescreen of regulation

June 28, 2010
Medical Communications, Sales and Marketing Janssen, social media

When framing a story for the media it is well known in the communications community that a successful piece must …

European regulator probes ARB cancer link

June 28, 2010
Sales and Marketing ARB, Amias, Aprovel, Cozaar, Diovan, Micardis

European regulators have begun an investigation into a possible risk of cancer in patients taking angiotensin II receptor inhibitors for …

The Gateway to Local Adoption Series

Latest content